Introduction: Chromogranin A (CgA) is regarded as a major, nonspecific marker of neuroendocrine tumors (NET). Its estimation appears helpful for diagnostic purposes and is particularly useful for monitoring the treatment of NET. It must be kept in mind, however, that various factors, drugs, or coexisting diseases may influence the outcome of CgA measurement in blood. One such analytical factor is the sort of studied biological material, whether it is plasma or serum. The aim of our study was to compare directly the results of CgA concentrations measured in serum and in plasma by IRMA and ELISA.
Material And Methods: We analysed 122 samples of EDTA-plasma and 122 samples of serum by IRMA method, 20 samples of EDTAplasma and 20 samples of serum by IRMA and ELISA, 25 heparinised-plasma samples and 25 samples of EDTA-plasma by IRMA and ELISA methods, and 8 EDTA-plasma, heparinised-plasma, and serum samples by IRMA and ELISA. The material for comparative study was obtained during the same blood collection from the same subjects (volunteers and patients with NET). CgA was measured with the use of kits manufactured by CIS bio International (France).
Results: CgA concentrations were markedly higher in plasma than in serum. Using the IRMA method, the difference in the CgA range between 10-100 ng/mL approached 20-70% (median 61 v. 42), in the range 101-300 ng/mL--12-60% (median 147 v. 101), and in the CgA range 301-1076 ng/mL--14-40% (median 486 v. 356). The differences between results in serum and plasma using ELISA were similar but slightly smaller. There was no significant difference between CgA levels in EDTA and heparinised-plasma samples, and the results of measurements performed by IRMA and ELISA in most cases were similar.
Conclusions: Referring each individual CgA result to the proposed reference range (or cut-off value) we must take into account whether the measurement is performed in plasma or in serum.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Plasma Non-Esterified Fatty Acid Levels Throughout Childhood and Its Relationship with Leptin Levels in Children.
J Clin Med
November 2024
Lipid Research Laboratory, IIS-Fundación Jiménez Díaz, UAM, 28040 Madrid, Spain.
The relationship of non-esterified fatty acid (NEFA) levels with obesity and obesity-related alterations shows age-dependent variability in children. Leptin, with an important role in energy homeostasis and lipid metabolism, may be related to NEFA levels throughout the first decades of life. This cross-sectional study aims to analyse plasma NEFA levels in children of different ages and evaluate the relationship of leptin with NEFA levels depending on age.
View Article and Find Full Text PDFOsteocalcin: A bone protein with multiple endocrine functions.
Clin Chim Acta
February 2025
Department of Clinical Chemistry, CHU de Liège, Centre de Recherche Intégré sur les Médicaments (CIRM), Liège, Belgium.
Bones are now recognised as endocrine organs with diverse functions. Osteocalcin, a protein primarily produced by osteoblasts, has garnered significant attention. Research into osteocalcin has revealed its impact on glucose metabolism and its unexpected endocrine role, particularly in its undercarboxylated form (ucOC).
View Article and Find Full Text PDFCircadian disruption and psychostimulants dysregulates plasma acute-phase proteins and circulating cell-free mitochondrial DNA.
Brain Behav Immun Health
August 2023
Department of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&M University, College Station, TX, 77843, USA.
Background: Previous studies have indicated a close link between the inflammatory response, exacerbated by circadian disruption and psychostimulants such as cocaine and methamphetamine (METH). Indicators of this inflammation include cortisol and acute-phase proteins (APPs) like C-reactive protein (CRP), complement C3 (C3), and serum amyloid A (SAA). The connection between these inflammation markers and circulating mitochondrial DNA (mtDNA) has been gaining attention.
View Article and Find Full Text PDFHow low is really low? Comparison of two C-peptide assays to establish residual C-peptide production in type 1 diabetes.
Diabet Med
May 2022
Department of Clinical Chemistry, IJsselland Hospital, Capelle aan den IJssel, The Netherlands.
Article Synopsis
- C-peptide is a key marker for assessing insulin production in type 1 diabetes (T1D), and accurate assays are essential for detecting tiny changes over time.
- A study compared two assays: the ultrasensitive Mercodia ELISA and Beckman IRMA, focusing on their performance in measuring low C-peptide levels.
- The Beckman IRMA showed better quantification capability than the Mercodia ELISA, emphasizing the need for establishing limits of quantification in assays before their use in research and clinical settings.
Pharmacokinetic Profile of Fentanyl in the Koala () after Intravenous Administration, and Absorption via a Transdermal Patch.
Animals (Basel)
December 2021
Sydney School of Veterinary Science, The University of Sydney, Camperdown, Sydney 2006, Australia.
Fentanyl was administered as a single intravenous bolus injection at 5 µg/kg to five koalas and fentanyl plasma concentrations for a minimum of 2 h were quantified by an enzyme-linked immunosorbent assay (ELISA). The median (range) fentanyl elimination half-life and clearance were 0.53 (0.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!